Expression of EGFR, HER-2/neu and KIT in germ cell tumours

Ignacio Durán1, Adelaida García-Velasco, Claudio Ballestín

  • 1Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain. duranign@gmail.com

Abstract

Insights

This study investigated tyrosine kinase receptor expression in germ cell tumors (GCTs). While EGFR, HER-2/neu, and KIT show varied expression by GCT subtype, they did not prove to be significant prognostic or predictive factors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Germ cell tumors (GCTs) are highly chemosensitive, yet 20-30% of advanced cases remain incurable.
  • Tyrosine kinase receptors are implicated in other cancers, but their role in GCTs is under-researched.

Purpose of the Study:

  • To investigate the expression patterns of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER-2)/neu, and KIT (CD117) in GCTs.
  • To evaluate these markers as potential predictive or prognostic factors in GCT patients.

Main Methods:

  • Immunohistochemistry was used to assess EGFR, HER-2/neu, and KIT expression in 109 GCT samples from 84 patients.
  • Univariate and multivariate analyses were conducted to determine the significance of marker expression.

Main Results:

  • EGFR and HER-2/neu were found in 28% and 13% of tumors, respectively, mainly in nonseminomatous GCTs.
  • KIT was highly expressed in seminomas (97%) but rare in choriocarcinoma and teratocarcinoma.
  • No significant association was found between marker expression and relapse-free or overall survival, though EGFR showed borderline inverse association with tumor response.

Conclusions:

  • EGFR, HER-2/neu, and KIT exhibit distinct expression profiles across GCT histological subtypes.
  • The studied tyrosine kinase receptors lack prognostic or predictive value in this patient cohort.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...